2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Pain
20
Neoplasms
19
Cancer Pain
16
Pain, Postoperative
12
Agnosia
8
Chronic Pain
7
Breast Neoplasms
5
Neoplasm Metastasis
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Multiple Myeloma
3
Mucositis
3
Lymphoma, Follicular
3
Lymphoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Leukemia, Biphenotypic, Acute
3
Leukemia
3
Wounds and Injuries
2
Waldenstrom Macroglobulinemia
2
Thrombocythemia, Essential
2
Supratentorial Neoplasms
2
Sezary Syndrome
2
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Polycythemia Vera
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Interventions
Cisplatin
280
pembrolizumab
234
Radiotherapy
171
Cetuximab
169
Carboplatin
123
Docetaxel
110
Paclitaxel
96
Fluorouracil
95
Nivolumab
88
Radiotherapy, Intensity-Modulated
80
Magnetic Resonance Spectroscopy
39
durvalumab
36
Radiation
33
Surgical Procedures, Operative
32
Drug Therapy
32
Biopsy
28
Radiosurgery
25
Erlotinib Hydrochloride
25
Albumin-Bound Paclitaxel
24
Taxes
23
130-nm albumin-bound paclitaxel
23
Specimen Handling
22
Platinum
22
Immunohistochemistry
21
tislelizumab
20
1,2-diaminocyclohexaneplatinum II citrate
20
Cyclophosphamide
19
Chemoradiotherapy
19
Capecitabine
19
tremelimumab
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Morphine
×
Clear all
NCT06875791
2025-04-01
TEMOR
Fundacion Clinica Valle del Lili
Phase 1/2
Not yet recruiting
40 enrolled